Search research articles
Contact Us
Filters
Showing results (31-40 of 89) with videos related to
Page
of 9
Sort By:
Cancer Research
|
March 3, 2007
Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells
Claudia Friesen, Gerhard Glatting, Bernd Koop, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 23, 2002
Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines
Ulrike Seitz, Martin Wagner, Bernd Neumaier, et al.
Nuclear Medicine and Biology
|
October 11, 2011
Auger electron emitter against multiple myeloma--targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4'-thio-2'-deoxyuridine
Agnieszka Morgenroth, Cornelia Dinger, Boris D Zlatopolskiy, et al.
BJU International
|
March 16, 2007
11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer
Ludwig Rinnab, Norbert M Blumstein, Felix M Mottaghy, et al.
Radiology
|
May 30, 2002
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings
Sabine Fenchel, Dieter Grab, Karin Nuessle, et al.
Medical Physics
|
May 6, 2004
Improving binding potential analysis in [11C]raclopride PET studies using cluster analysis
Gerhard Glatting, Felix M Mottaghy, Jochen Karitzky, et al.
Nuclear Medicine and Biology
|
March 27, 2007
Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLT
Andreas T J Vogg, Andreas K Buck, Michaela Schmid, et al.
Neuroimage
|
January 5, 2002
Dissociating a common working memory network from different neural substrates of phonological and spatial stimulus processing
Bartosz Zurowski, Julia Gostomzyk, Georg Grön, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2003
A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy
Inga Buchmann, Thomas Kull, Gerhard Glatting, et al.
Medical Physics
|
September 11, 2012
Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy
Peter Kletting, Berthold Muller, Bahar Erentok, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 89) with videos related to
Sort By:
Page
of 9
Cancer Research
|
March 3, 2007
Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells
Claudia Friesen, Gerhard Glatting, Bernd Koop, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 23, 2002
Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines
Ulrike Seitz, Martin Wagner, Bernd Neumaier, et al.
Nuclear Medicine and Biology
|
October 11, 2011
Auger electron emitter against multiple myeloma--targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4'-thio-2'-deoxyuridine
Agnieszka Morgenroth, Cornelia Dinger, Boris D Zlatopolskiy, et al.
BJU International
|
March 16, 2007
11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer
Ludwig Rinnab, Norbert M Blumstein, Felix M Mottaghy, et al.
Radiology
|
May 30, 2002
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings
Sabine Fenchel, Dieter Grab, Karin Nuessle, et al.
Medical Physics
|
May 6, 2004
Improving binding potential analysis in [11C]raclopride PET studies using cluster analysis
Gerhard Glatting, Felix M Mottaghy, Jochen Karitzky, et al.
Nuclear Medicine and Biology
|
March 27, 2007
Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLT
Andreas T J Vogg, Andreas K Buck, Michaela Schmid, et al.
Neuroimage
|
January 5, 2002
Dissociating a common working memory network from different neural substrates of phonological and spatial stimulus processing
Bartosz Zurowski, Julia Gostomzyk, Georg Grön, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2003
A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy
Inga Buchmann, Thomas Kull, Gerhard Glatting, et al.
Medical Physics
|
September 11, 2012
Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy
Peter Kletting, Berthold Muller, Bahar Erentok, et al.
Page
of 9